Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples